Genomics biomarker good practice consultation
The European Medicines Agency (EMA) has produced a concept paper for consultation on good practice in the use of genomic data and biomarkers in medicines development and safety monitoring. Responses to the consultation should be sent to firstname.lastname@example.org. The closing date for submissions is 31 October 2014.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066079
Recommended from Pharmaceutical Press